SKAN Group AG
SIX:SKAN

Watchlist Manager
SKAN Group AG Logo
SKAN Group AG
SIX:SKAN
Watchlist
Price: 74 CHF -0.8%
Market Cap: 1.7B CHF
Have any thoughts about
SKAN Group AG?
Write Note

SKAN Group AG
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SKAN Group AG
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
SKAN Group AG
SIX:SKAN
Total Liabilities & Equity
CHf373.4m
CAGR 3-Years
13%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Total Liabilities & Equity
CHf1.7B
CAGR 3-Years
31%
CAGR 5-Years
23%
CAGR 10-Years
15%
Siegfried Holding AG
SIX:SFZN
Total Liabilities & Equity
CHf1.9B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Total Liabilities & Equity
CHf16.8B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
10%
Tecan Group AG
SIX:TECN
Total Liabilities & Equity
CHf2.1B
CAGR 3-Years
22%
CAGR 5-Years
19%
CAGR 10-Years
N/A
PolyPeptide Group AG
SIX:PPGN
Total Liabilities & Equity
€689.1m
CAGR 3-Years
22%
CAGR 5-Years
19%
CAGR 10-Years
N/A
No Stocks Found

SKAN Group AG
Glance View

Market Cap
1.7B CHF
Industry
Life Sciences Tools & Services

SKAN Group AG engages in the development, design, and manufacture of process isolators for the aseptic filling of biopharmaceutical products. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2007-04-05. The company concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The firm acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.

SKAN Intrinsic Value
93.59 CHF
Undervaluation 21%
Intrinsic Value
Price

See Also

What is SKAN Group AG's Total Liabilities & Equity?
Total Liabilities & Equity
373.4m CHF

Based on the financial report for Dec 31, 2023, SKAN Group AG's Total Liabilities & Equity amounts to 373.4m CHF.

What is SKAN Group AG's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
31%

Over the last year, the Total Liabilities & Equity growth was -4%. The average annual Total Liabilities & Equity growth rates for SKAN Group AG have been 13% over the past three years , 31% over the past five years .

Back to Top